| Revenue growth | Q4 FY26 revenue grew 22% YoY; FY26 revenue grew 11% YoY. |
|---|---|
| Margins | EBITDA margin sustained at 17.8% despite expansion overheads and supply disruptions. |
| Order book | Provisional approval from global customers for lithium electrolyte salts. |
| Demand visibility | Sustained visibility across core products; giga-scale battery manufacturing demand increasing. |
| Management confidence | High confidence in lithium-ion ecosystem and long-term growth trajectory. |
Growth
FY26 revenue reached ₹862 crore (+11% YoY). Q4 growth driven by volumes in specialty chemicals and inorganic segments.
Outlook
FY27 standalone revenue guidance: ₹875–950 crore. Pakhajan Phase 2 completion March 2027; battery chemical revenue target ₹300cr+ in FY27.
Risks
Pricing volatility in lithium/bromine, Middle East geopolitical supply chain disruptions, and temporary costs from Dahej facility reconstruction.
Earnings Call filed with NSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,385.20
- Market cap
- ₹7,166 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 201.5×Sector 37.5×
- Promoter holding
- 48.31%-2.92% QoQ
- FII holding
- 4.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Capital Structure Change
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
- Value
- ₹76.80 Cr
Neogen Chemicals Credit Rating
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals Debt & Borrowing: ₹1.63 Cr
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
- Value
- ₹1.63 Cr
Neogen Chemicals Other Announcement
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Capital Structure Change
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals Fund Raise of ₹600 Cr
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
- Value
- ₹600.0 Cr